Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 8;23(1):e0108.
doi: 10.1097/CLD.0000000000000108. eCollection 2024 Jan-Jun.

Patients treated with immune checkpoint inhibitors for HCC should not be considered for liver transplant

Frances Lee  1 , Ann Robinson  1 , Edward Will Holt  2 , R Todd Frederick  2
Affiliations

Patients treated with immune checkpoint inhibitors for HCC should not be considered for liver transplant

Frances Lee et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

R. Todd Frederick consults for, advises, and received grants from Mallinckrodt. He consults for Tennor and Seal Rock. He received grants from Salix/Bausch. The remaining authors have no conflicts to report.

Figures

None
Graphical abstract
See this image and copyright information in PMC

References

    1. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. . Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–1606. - PMC - PubMed
    1. Woo SM, Kimchy AV, Sequeira LM, Dorris CS, He AR, Rangnekar AS. Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma. Curr Oncol. 2022;29:9813–9825. - PMC - PubMed
    1. United Network for Organ Sharing . Guidance to Liver Transplant Programs and the National Liver Review Board for: Adult MELD Exceptions for Hepatocellular Carcinoma (HCC). John Wiley and Sons Inc; 2023.
    1. Ju MR, Yopp AC. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Ann Gastroenterol Surg. 2020;4:208–215. - PMC - PubMed
    1. Choi HJ, Kim DG, Na GH, Hong TH, Bae SH, You YK, et al. . The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation. Liver Transpl. 2017;23:1023–1031. - PubMed